Agile Therapeutics to Present at the 27th Annual ROTH Conference
02 3월 2015 - 9:58PM
Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty
pharmaceutical company focused on the development and
commercialization of new prescription contraceptive products,
announced today that Al Altomari, President and Chief Executive
Officer will present at the 27th Annual ROTH Conference on Monday,
March 9, 2015 at 4:30 PM Pacific Time.
To access the live and archived webcasts of the presentation,
visit the Investor Relations section of Agile Therapeutics website
at www.agiletherapeutics.com. The webcast will be archived on Agile
Therapeutics website for 60 days following the event.
About Agile
Agile Therapeutics is a women's health specialty pharmaceutical
company focused on the development and commercialization of new
prescription contraceptive products. Our product candidates are
designed to provide women with contraceptive options that offer
greater convenience and facilitate compliance. Our lead product
candidate, Twirla®, (ethinyl estradiol and levonorgestrel
transdermal system), also known as AG200-15, is a once-weekly
prescription contraceptive patch currently in Phase 3 clinical
development. Twirla is based on our proprietary transdermal patch
technology, called Skinfusion®, which is designed to provide
advantages over currently available patches and is intended to
optimize patch adherence and patient acceptability. For more
information, please visit the company website at
www.agiletherapeutics.com.
CONTACT: Mary Coleman
609-683-1880
Agile Therapeutics (NASDAQ:AGRX)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Agile Therapeutics (NASDAQ:AGRX)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024